Page last updated: 2024-08-22

platinum and Cancer of Pelvis

platinum has been researched along with Cancer of Pelvis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M	1
Boxall, J; Collins, DJ; d'Arcy, JA; Lankester, KJ; Leach, MO; Padhani, AR; Rustin, GJ; Stirling, JJ; Taylor, JN; Walker-Samuel, S	1
Hoskins, WJ; Jones, WB; Lewis, JL; Rubin, SC; Vaccarello, L; Vlamis, V; Wong, G	1

Trials

1 trial(s) available for platinum and Cancer of Pelvis

Article	Year
Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors. Journal of magnetic resonance imaging : JMRI, 2007, Volume: 25, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bridged-Ring Compounds; Female; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pelvic Neoplasms; Platinum; Regional Blood Flow; Reproducibility of Results; Taxoids	2007

Article

Year

Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors.

Journal of magnetic resonance imaging : JMRI, 2007, Volume: 25, Issue:4

Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bridged-Ring Compounds; Female; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pelvic Neoplasms; Platinum; Regional Blood Flow; Reproducibility of Results; Taxoids

2007

Other Studies

2 other study(ies) available for platinum and Cancer of Pelvis

Article	Year
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3. Endocrine-related cancer, 2012, Volume: 19, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome	2012
Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecologic oncology, 1995, Volume: 57, Issue:1 Topics: Abdominal Neoplasms; Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Platinum; Reoperation; Retrospective Studies; Survival Analysis	1995

Article

Year

FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.

Endocrine-related cancer, 2012, Volume: 19, Issue:6

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome

2012

Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.

Gynecologic oncology, 1995, Volume: 57, Issue:1

Topics: Abdominal Neoplasms; Adult; Aged; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Platinum; Reoperation; Retrospective Studies; Survival Analysis

1995